Evidence map›Paper›PMID 25377550›Full record

ArticleDevelopment (Cambridge, England)2014

The lipoprotein receptor LRP1 modulates sphingosine-1-phosphate signaling and is essential for vascular development.

Chikako Nakajima, Philipp Haffner, Sebastian M Goerke, Kai Zurhove, Giselind Adelmann, Michael Frotscher, Joachim Herz, Hans H Bock, Petra May

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Tale of 2 Receptors.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Lrp1 Regulation of Pulmonary Function. Follow-Up of Human GWAS in Mice.American journal of respiratory cell and molecular biology · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Chikako NakajimaDepartment of Medicine II, University Hospital and University of Freiburg, 79106 Freiburg, Germany Centre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany Institute of Physiological Chemistry and Focus Program Translational Neuroscience (Adult Neurogenesis and Cellular Reprogramming), University Medical Center, Johannes Gutenberg University Mainz, 55128 Mainz, Germany Department of Gastroenterology, Hepatology and Infectiology, University Hospital of Düsseldorf, 40225 Düsseldorf, Germany.
Philipp HaffnerCentre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany.
Sebastian M GoerkeCentre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany Department of Plastic and Hand Surgery, University Hospital and University of Freiburg, 79106 Freiburg, Germany.
Kai ZurhoveDepartment of Medicine II, University Hospital and University of Freiburg, 79106 Freiburg, Germany Centre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany.
Giselind AdelmannInstitute of Anatomy and Cell Biology, University Hospital and University of Freiburg, 79104 Freiburg, Germany.
Michael FrotscherInstitute for Structural Neurobiology, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Joachim HerzCentre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany Department for Molecular Genetics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
Hans H BockDepartment of Medicine II, University Hospital and University of Freiburg, 79106 Freiburg, Germany Centre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany Department of Gastroenterology, Hepatology and Infectiology, University Hospital of Düsseldorf, 40225 Düsseldorf, Germany.
Petra MayDepartment of Medicine II, University Hospital and University of Freiburg, 79106 Freiburg, Germany Centre for Neurosciences, University Hospital and University of Freiburg, 79104 Freiburg, Germany Department of Gastroenterology, Hepatology and Infectiology, University Hospital of Düsseldorf, 40225 Düsseldorf, Germany petra.may@med.uni-duesseldorf.de.
University of Freiburg · DEHeinrich Heine University Düsseldorf · DEThe University of Texas Southwestern Medical Center · USUniversität Hamburg · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

TRANSCRIPTIONAL REGULATION OF LDL RECEPTOR PROMOTERP01HL020948 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GOLDSTEIN, JOSEPH L · 1985 to 2021
$103.1M
Metabolism of the VLDL receptor and ApoE receptor 2R37HL063762 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HERZ, JOACHIM J · 2010 to 2019
$4.0M
METABOLISM OF THE VLDL RECEPTOR AND APOE RECEPTOR 2R01HL063762 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HERZ, JOACHIM J · 2000 to 2009
$3.1M
NHLBI NIH HHS HL20948NHLBI NIH HHS HL63762NHLBI NIH HHS P01 HL020948NHLBI NIH HHS R01 HL063762NHLBI NIH HHS R37 HL063762PHS HHS RCINS068697
6 · The paper itself

Abstract

Low density lipoprotein receptor-related protein 1 (LRP1) is indispensable for embryonic development. Comparing different genetically engineered mouse models, we found that expression of Lrp1 is essential in the embryo proper. Loss of LRP1 leads to lethal vascular defects with lack of proper investment with mural cells of both large and small vessels. We further demonstrate that LRP1 modulates Gi-dependent sphingosine-1-phosphate (S1P) signaling and integrates S1P and PDGF-BB signaling pathways, which are both crucial for mural cell recruitment, via its intracellular domain. Loss of LRP1 leads to a lack of S1P-dependent inhibition of RAC1 and loss of constraint of PDGF-BB-induced cell migration. Our studies thus identify LRP1 as a novel player in angiogenesis and in the recruitment and maintenance of mural cells. Moreover, they reveal an unexpected link between lipoprotein receptor and sphingolipid signaling that, in addition to angiogenesis during embryonic development, is of potential importance for other targets of these pathways, such as tumor angiogenesis and inflammatory processes.

Indexed as

AnimalsBecaplerminBlotting, WesternCell MovementEmbryonic DevelopmentGenetic EngineeringHumansHuman Umbilical Vein Endothelial CellsImmunohistochemistryIn Situ HybridizationLow Density Lipoprotein Receptor-Related Protein-1LysophospholipidsMiceMicroscopy, ElectronNeovascularization, PhysiologicProto-Oncogene Proteins c-sisBecaplerminLow Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseLysophospholipidsProto-Oncogene Proteins c-sisReceptors, LDLSphingosinesphingosine 1-phosphateTumor Suppressor ProteinsAngiogenesisLipoprotein receptorSphingolipid

Identifiers

PMID25377550
PMCPMC4302929
OpenAlexW2055009677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.